Prostate Cancer
FEATURES
avatar
3206 clinical trials
avatar
62 cell line models
avatar
14 approved drugs
IMAGE
Prostate Cancer
Molecular Synopsis
OVERVIEW
Drugs and clinical candidates

14 drugs have received FDA approval for Prostate Cancer:

  • (R)-BICALUTAMIDE
  • 223
  • Abiraterone Acetate
  • Cabazitaxel
  • Degarelix
More

430 drugs have a clinical trial registered for Prostate Cancer.

10144 compounds have been tested in Prostate Cancer (6042 <= 500nM potency).

Sources: cancer.gov, clinicaltrials.gov, ChEMBL.

Clinical trials
There are 3206 clinical trials for Prostate Cancer, 1613 of which have one or more drug interventions, 1593 with no drug intervention.
Cell line models

There are 62 Cell Line Models for Prostate Cancer.

Source: COSMIC
Cell line models

Please note the mappings below are based on an imperfect algorithm. If you notice any anomalies please report them to us.

The following terms have been mapped from clinicaltrials.gov mesh condition terms to Prostate Cancer:
  • Prostatic Neoplasms
  • Prostatic Neoplasms, Castration-Resistant
The following terms have been mapped from cancer.gov to Prostate Cancer:
  • Prostate cancer that is castration resistant (has not responded to treatments that lower testosterone levels). It is used in patients whose disease has metastasized (spread) to the bones and is causing symptoms but has not spread to other organs
  • Prostate cancer. It is used as palliative treatment in advanced disease that is hormone-refractory (does not respond to hormone treatment)
  • Prostate cancer that has metastasized in men whose cancer is hormone-refractory (does not respond to hormone treatment)
  • Prostate cancer that has not metastasized (spread to other parts of the body) and is castration resistant (has not responded to treatments that lower testosterone levels)
  • Prostate cancer that has metastasized (spread to other parts of the body). It is used in patients who have had surgery to remove the testicles (orchiectomy)
More